Myeloperoxidase and Multi-Markers In the Diagnosis of Diagnoses of Acute Coronary Syndrome (MIDAS) - Sample Procurement

CompletedOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

December 31, 2006

Study Completion Date

June 30, 2008

Conditions
Acute Coronary Syndrome (ACS)
Interventions
DEVICE

Biomarkers

Trial Locations (18)

Unknown

UC Davis, Sacramento

Yale University, New Haven

St Agnes Hospital, Baltimore

Beth Israel Deaconess Medical Center, Boston

Brigham & Women's Hospital, Boston

Massachusetts General Hospital, Boston

Henry Ford Health System, Detroit

Spectrum Health Hospitals, Grand Rapids

Ingham Regional Medical Center, Lansing

New York Methodist Hosptial, Brooklyn

SUNY Stony Brook, Stony Brook

Duke University Medical Center, Durham

Wake Forest University School of Medicine, Winston-Salem

Cleveland Clinic Foundation, Cleveland

Ohio State University Medical Center, Columbus

University of Virginia, Charlottesville

Sentara Norfolk General Hopsital, Norfolk

Virginia Commonwealth University Medical Center, Richmond

All Listed Sponsors
lead

Abbott RDx Cardiometabolic

OTHER

NCT00415948 - Myeloperoxidase and Multi-Markers In the Diagnosis of Diagnoses of Acute Coronary Syndrome (MIDAS) - Sample Procurement | Biotech Hunter | Biotech Hunter